Delivery Order SPE2DR25D3004-SPE2DR26FXWL4
- Not listed
- The Defense Logistics Agency awarded a $40,234.19 delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams), with an ultimate completion date of December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,929.92 delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $1,513.53 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities. This firm fixed-price contract, which is not set-aside for any specific business category, is scheduled for completion by June 23, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,459.47 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% cream in 60-gram units. This competitive award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, is structured as a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a $6,822.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $20,264.36 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXWL4Delivery Order
The Defense Logistics Agency awarded a $1,412.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside competitive award with a completion date of February 5, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026 that enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly for the Department of Defense and military healthcare systems. The company's extensive portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Opzelura, a topical pharmaceutical product, reflects the company's continued role in fulfilling operational medical supply needs across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/3/26 |